315 related articles for article (PubMed ID: 32447485)
1. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
2. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
Huang K; Tang Y; He L; Dai Y
Oncol Rep; 2016 Feb; 35(2):887-95. PubMed ID: 26718483
[TBL] [Abstract][Full Text] [Related]
4. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
5. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD; Yuan YL; Yu HB; Tian GJ; Li DY
Oncol Rep; 2019 Mar; 41(3):1649-1657. PubMed ID: 30592290
[TBL] [Abstract][Full Text] [Related]
6. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
7. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of SRPK2 contributes to aggressive progression and metastasis in prostate cancer.
Zhuo YJ; Liu ZZ; Wan S; Cai ZD; Xie JJ; Cai ZD; Song SD; Wan YP; Hua W; Zhong W; Wu CL
Biomed Pharmacother; 2018 Jun; 102():531-538. PubMed ID: 29587239
[TBL] [Abstract][Full Text] [Related]
9. SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.
Feng W; Li HC; Xu K; Chen YF; Pan LY; Mei Y; Cai H; Jiang YM; Chen T; Feng DX
Gene; 2016 Aug; 587(1):91-7. PubMed ID: 27129942
[TBL] [Abstract][Full Text] [Related]
10. Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells.
Tao HC; Wang HX; Dai M; Gu CY; Wang Q; Han ZG; Cai B
Asian Pac J Cancer Prev; 2013; 14(10):5645-50. PubMed ID: 24289556
[TBL] [Abstract][Full Text] [Related]
11. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.
Shi W; Zhang G; Ma Z; Li L; Liu M; Qin L; Yu Z; Zhao L; Liu Y; Zhang X; Qin J; Ye H; Jiang X; Zhou H; Sun H; Jiao Z
Nat Commun; 2021 May; 12(1):2812. PubMed ID: 33990570
[TBL] [Abstract][Full Text] [Related]
12. SHCBP1 Promotes Papillary Thyroid Carcinoma Carcinogenesis and Progression Through Promoting Formation of Integrin and Collagen and Maintaining Cell Stemness.
Geng H; Guo M; Xu W; Zang X; Wu T; Teng F; Wang Y; Liu X; Wang X; Sun Q; Liang J
Front Endocrinol (Lausanne); 2020; 11():613879. PubMed ID: 33716952
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA TP53TG1 Upregulates SHCBP1 to Promote Retinoblastoma Progression by Sponging miR-33b.
Wang H; Zhang Z; Zhang Y; Liu S; Li L
Cell Transplant; 2021; 30():9636897211025223. PubMed ID: 34247545
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
15. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of TRPM7 suppressed migration and invasion by regulating epithelial-mesenchymal transition in prostate cancer cells.
Chen L; Cao R; Wang G; Yuan L; Qian G; Guo Z; Wu CL; Wang X; Xiao Y
Med Oncol; 2017 Jul; 34(7):127. PubMed ID: 28573641
[TBL] [Abstract][Full Text] [Related]
17. SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression.
Gao W; Qi CQ; Feng MG; Yang P; Liu L; Sun SH
J Cell Physiol; 2020 Oct; 235(10):6684-6696. PubMed ID: 32003010
[TBL] [Abstract][Full Text] [Related]
18. Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway.
Dai Y; Hu C; Zhou H; Liu W; Lai W; Xu R; Liao J; Wang J; Li G; Zhang R
FEBS J; 2023 Dec; 290(24):5720-5743. PubMed ID: 37581853
[TBL] [Abstract][Full Text] [Related]
19. SHCBP1 interacting with EOGT enhances O-GlcNAcylation of NOTCH1 and promotes the development of pancreatic cancer.
Yang C; Hu JF; Zhan Q; Wang ZW; Li G; Pan JJ; Huang L; Liao CY; Huang Y; Tian YF; Shen BY; Chen JZ; Wang YD; Chen S
Genomics; 2021 Mar; 113(2):827-842. PubMed ID: 33515675
[TBL] [Abstract][Full Text] [Related]
20. Cullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.
Jiang H; He D; Xu H; Liu J; Qu L; Tong S
Int J Clin Exp Pathol; 2015; 8(2):1575-83. PubMed ID: 25973042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
